Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Thalassemia market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Thalassemiamarket, defines the market attractiveness level of Thalassemia market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Thalassemia industry, describes the types of Thalassemia market, the applications of major players and the market size, and deeply analyzes the current situation of the global Thalassemia market and the development prospects and opportunities of Thalassemia industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Thalassemia market in Chapter 13.
By Player:
IONIS Pharmaceuticals
Kiadis Pharma
Bluebird bio Inc
Celgene Corporation
La Jolla Pharmaceutical Company
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Acceleron Pharma Inc
By Type:
Iron Chelating Drugs
Others
By End-User:
Hospital
Clinic
Research Institute
Laboratories
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Thalassemia Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Thalassemia Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Thalassemia Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Thalassemia Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Thalassemia Market Analysis and Outlook to 2022
-
7.1 Global Thalassemia Consumption (2017-2022)
-
7.2 United States Thalassemia Consumption (2017-2022)
-
7.3 Europe Thalassemia Consumption (2017-2022)
-
7.4 China Thalassemia Consumption (2017-2022)
-
7.5 Japan Thalassemia Consumption (2017-2022)
-
7.6 India Thalassemia Consumption (2017-2022)
-
7.7 South Korea Thalassemia Consumption (2017-2022)
8 Region and Country-wise Thalassemia Market Analysis and Outlook to 2028
-
8.1 Global Thalassemia Consumption Forecast (2022-2028)
-
8.2 United States Thalassemia Consumption Forecast (2022-2028)
-
8.3 Europe Thalassemia Consumption Forecast (2022-2028)
-
8.4 China Thalassemia Consumption Forecast (2022-2028)
-
8.5 Japan Thalassemia Consumption Forecast (2022-2028)
-
8.6 India Thalassemia Consumption Forecast (2022-2028)
-
8.7 South Korea Thalassemia Consumption Forecast (2022-2028)
9 Global Thalassemia Market Outlook by Types and Applications to 2022
-
9.1 Global Thalassemia Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Iron Chelating Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Thalassemia Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Laboratories Consumption and Growth Rate (2017-2022)
10 Global Thalassemia Market Outlook by Types and Applications to 2028
-
10.1 Global Thalassemia Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Iron Chelating Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Thalassemia Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
11 Global Thalassemia Import and Export Analysis (Top 5 Countries)
-
11.1 Global Thalassemia Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Thalassemia Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Thalassemia Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Thalassemia Market Competitive Analysis
-
14.1 IONIS Pharmaceuticals
-
14.1.1 IONIS Pharmaceuticals Company Details
-
14.1.2 IONIS Pharmaceuticals Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 IONIS Pharmaceuticals Thalassemia Product and Service
-
14.2 Kiadis Pharma
-
14.2.1 Kiadis Pharma Company Details
-
14.2.2 Kiadis Pharma Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Kiadis Pharma Thalassemia Product and Service
-
14.3 Bluebird bio Inc
-
14.3.1 Bluebird bio Inc Company Details
-
14.3.2 Bluebird bio Inc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bluebird bio Inc Thalassemia Product and Service
-
14.4 Celgene Corporation
-
14.4.1 Celgene Corporation Company Details
-
14.4.2 Celgene Corporation Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Celgene Corporation Thalassemia Product and Service
-
14.5 La Jolla Pharmaceutical Company
-
14.5.1 La Jolla Pharmaceutical Company Company Details
-
14.5.2 La Jolla Pharmaceutical Company Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 La Jolla Pharmaceutical Company Thalassemia Product and Service
-
14.6 GlaxoSmithKline plc
-
14.6.1 GlaxoSmithKline plc Company Details
-
14.6.2 GlaxoSmithKline plc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline plc Thalassemia Product and Service
-
14.7 Incyte Corporation
-
14.7.1 Incyte Corporation Company Details
-
14.7.2 Incyte Corporation Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Incyte Corporation Thalassemia Product and Service
-
14.8 Gamida Cell
-
14.8.1 Gamida Cell Company Details
-
14.8.2 Gamida Cell Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Gamida Cell Thalassemia Product and Service
-
14.9 Acceleron Pharma Inc
-
14.9.1 Acceleron Pharma Inc Company Details
-
14.9.2 Acceleron Pharma Inc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Acceleron Pharma Inc Thalassemia Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Thalassemia
-
Figure Thalassemia Picture
-
Table Global Thalassemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Thalassemia Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Thalassemia Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Thalassemia Consumption by Country (2017-2022)
-
Figure United States Thalassemia Consumption and Growth Rate (2017-2022)
-
Table Europe Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure China Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Japan Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure India Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure South Korea Thalassemia Consumption and Growth Rate (2017-2022)
-
Figure Global Thalassemia Consumption Forecast by Country (2022-2028)
-
Figure United States Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Thalassemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iron Chelating Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Iron Chelating Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Thalassemia Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Thalassemia Export by Region (Top 5 Countries) (2017-2028)
-
Table IONIS Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table IONIS Pharmaceuticals Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table IONIS Pharmaceuticals Thalassemia Product and Service
-
Table Kiadis Pharma (Foundation Year, Company Profile and etc.)
-
Table Kiadis Pharma Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kiadis Pharma Thalassemia Product and Service
-
Table Bluebird bio Inc (Foundation Year, Company Profile and etc.)
-
Table Bluebird bio Inc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird bio Inc Thalassemia Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Thalassemia Product and Service
-
Table La Jolla Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table La Jolla Pharmaceutical Company Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table La Jolla Pharmaceutical Company Thalassemia Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Thalassemia Product and Service
-
Table Incyte Corporation (Foundation Year, Company Profile and etc.)
-
Table Incyte Corporation Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corporation Thalassemia Product and Service
-
Table Gamida Cell (Foundation Year, Company Profile and etc.)
-
Table Gamida Cell Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gamida Cell Thalassemia Product and Service
-
Table Acceleron Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Acceleron Pharma Inc Thalassemia Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acceleron Pharma Inc Thalassemia Product and Service
-
